The short-term effects of cisplatin chemotherapy on bone turnover

Journal of Bone and Mineral Research

Volumn 12, Issue 11, 1997, Pages 1874-1882

  Young, David R ^a   Virolainen, Petri ^a   Inoue, Nozomu ^a   Frassica, Frank J ^a   Chao, Edmund Y S ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CISPLATIN; OSTEOCALCIN; PYRIDINOLINE;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; BONE TURNOVER; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DOG; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORTHOPEDIC SURGERY; OSSIFICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD;

EID: 0030726412     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.11.1874     Document Type: Article

References (33)

1. Bacci G, Picci P, Ferrari S, Ruggieri P, Casadei P, Tienghi A, Brach del Prever A, Gherlinzoni F, Mercuri M, Monti C 1993 Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities: Results in 164 patients preoperatively treated with high doses of methotrexate followed by ciplatin and doxorubicin. Cancer 72:3227-3238.
2. Eilber FR, Morton DL, Eckardt J, Grant T, Weisenburger T 1984 Limb salvage for skeletal and soft tissue sarcomas: Multidisciplinary therapy. Cancer 53:2579-2584.
3. Hudson M, Jaffe MR, Jaffe N, Ayala A, Raymond AK, Carruso H, Wallace S, Murray J, Robertson R 1990 Pediatric osteosarcoma: Therapeutic strategies, results, and prognostic factors derived from a 10-year experience. J Clin Oncol 8:217-221.
4. Jaffe N, Patel SR, Benjamin RS 1995 Chemotherapy in osteosarcoma: Basis for application and antagonism to implementation: Early controversies surrounding its implementation. Hem Oncol Clin North Am 9:825-840.
5. Lane JM, Hurson B, Boland B, Glasser DB 1986 Osteogenic sarcoma. Clin Orthop 204:93-110.
6. Raymond AK, Chawla SP, Carrasco CH, Ayala AG, Fanning CV, Grice B, Armen T, Plager C, Papadopoulus NE, Edeiken J 1987 Osteosarcoma chemotherapy effect: A prognostic factor. Sem Diagn Pathol 4:212-236.
7. Rosen G 1987 Preoperative (neoadjuvant) chemotherapy for osteogenic sarcoma: A ten year experience. Orthopaedics 8:659-664.
8. Rosen G 1988 Bone and soft tissue sarcomas. Surg Ann 20:121-144.
9. Wanebo HJ, Glicksman AS, Landman C, Slotman G, Doolittle C, Clark J, Koness RJ 1995 Preoperative cisplatin and accelerated hyperfractioned radiation induces high tumor response and control in patients with advances head and neck cancer. Am J Surg 170:512-516.
10. Amsel S, Dell ES 1971 Response of the preosteoblast and stem cell of rat bone marrow to a lethal dose of X-irradiation or cyclophosphamide. Cell Tissue Kinet 4:255-261.
11. Friedlaender GE, Tross RB, Doganis AC, Kirkwood JM, Baron R 1987 Effects of chemotherapeutic agents on bone: Short term methotrexate and doxorubin treatment in a rat model. J Bone Joint Surg 69A:786-790.
12. McManus PM, Weiss L 1984 Busulfan-induced chronic bone marrow failure: Changes in cortical bone, marrow stromal cells, and adherent cell colonies. Blood 64:1036-1041.
13. Nilsson OS, Bauer FCH, Brostrom L-A, Nilsonne U 1984 Effect of the antineoplastic agent methotrexate on experimental heterotopic new bone formation in rats. Cancer Res 44:1653-1655.
14. Nilsson OS, Bauer FCH, Bronstrom L-A 1990 Comparison of the effects of adriamycin and methotrexate on orthotopic and induced heterotopic bone in rats. J Orthop Res 8:199-204.
15. Pelker RR, Friedlaender GE, Panjabi MM, Hausman M, Doganis AC, McKay J 1985 Chemotherapy-induced alternations in the biomechanics of rat bone. J Orthop Res 3:91-95.
16. Kother M, Schindler J, Oette K, Berthold F 1992 Abnormalities in serum osteocalcin values in children receiving chemotherapy including ifosfamide. In Vivo 6:219-221.
17. O'Regan S, Melhorn DK, Newman AJ 1973 Methotrexate-induced bone pain in childhood leukemia. Am J Dis Child 126:489-490.
18. Ragab AH, French RS, Vietti TJ 1970 Osteoporotic fractures to methotrexate therapy of acute leukemia in remission. Cancer 25:580-585.
19. Slovik DM, Gundberg CM, Neer RM, Lian JB 1984 Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. J Clin Endocrinol Metab 59:228-230.
20. Valentin-Opran A, Charhon SA, Meunier PJ, Edouard CM, Arlot ME 1982 Quantitave histology of myeloma-induced bone changes. Br J Haemat 52:601-610.
21. Wada S, Katayama Y, Yasumoto Y, Kugai N, Nagata N 1993 Changes of bone metabolic markers in patients with bone metastases: Clinical significance in assessing bone response to chemotherapy. Intern Med 32:611-618.
22. Priesner D, Sternson LA, Repta AJ 1981 Analysis of total platinum in tissue samples by flameless atomic absorption spectrophotometry: Elimination of the need for sample digestion. Anal Lett 14:1255-1268.
23. Frost HM 1983 Bone histomorphometry: Choice of marking agent and labeling schedule. In: Recker RR (ed.) Bone histomorphometry: Techniques and Interpretation. CRC Press Inc., Boca Raton, FL, U.S.A., pp. 37-52.
24. Jowsey J, Kelly PJ, Riggs BL, Bianco AJ, Gershon-Cohen JG 1965 Quantitative micrographic studies of normal and osteoporotic bone. J Bone Joint Surg 47A:785-806.
25. Litterst CL, LeRoy AF, Guarino AM 1979 Disposition and distribution of platinum following parental administration of cis-dichlorodiammineplatinum(II) to animals. Cancer Treat Rep 63:1485-1492.
26. Gullo JJ, Litterst CL, Maguire PJ, Sikie BI, Hoth DF, Woolley PV 1980 Pharmacokinetics and protein binding of cis-dichlordiammine platinum (II) administered as a one hour or as a twenty hour infusion. Cancer Chemother Pharmacol 5:21-26.
27. Vermorken JB, van der Vijgh WJF, Klein I, Hart AAM, Gall HE, Pinedo HM 1984 Pharmocokinetics of free and total platinum species after short-term infusion of cisplatin. Cancer Treat Rep 68:505-513.
28. Hauschka PV, Wians FH 1989 Osteocalcin-hydroxyapatite interaction in the extracellular organic matrix of bone. Anat Rec 224:180-188.
29. Stein GS, Lian JB, Gerstenfeld L, Shaloub V, Aronow M, Owen T, Markose E 1989 The onset and proression of osteoblast differentation is functionally related to cellular proliferation. Connect Tissue Res 20:3-13.
30. Delmas PP, Schlemmer A, Gineyts E 1991 Urinary excretion of pyridinoline cross-links correlates with bone turnover measured on iliac crest biology in patients with vertebral osteoporosis. J Bone Miner Res 6:639-644.
31. Einhorn TA, Simon G, Devlin VJ, Warman J, Sidhu SPS, Vigorita VJ 1990 The osteogenic response to distant skeletal injury. J Bone Joint Surg 72A:1374-1378.
32. Khoo DBA 1992 The effect of chemotherapy on soft tissue and bone healing in the rabbit model. Ann Acad Med 21:217-221.
33. Terheggen PMAB, Emondt JY, Floot BGJ, Dijkman R, Schrier PI, den Engelse L, Begg AC 1990 Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of cis-diamminedichloroplatinum(II)-DNA antiserum. Cancer Res 50:3556-3561.